Lexeo Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last report0 of 6 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+1.88%
vs ±70.2% implied · ×0.03
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
Lexeo Therapeutics, Inc.
3.14
+0.08 · +2.61%
post 3.14 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Suvretta Capital ManagementSuvretta | $29.7M | 7.23% | +410.74% | |
| 2 | Affinity Asset AdvisorsAffinity Asset | $27.0M | 6.58% | +15.00% | |
| 3 | BlackRockBlackRockindex-like | $26.7M | 6.50% | +12.30% | |
| 4 | RA Capital ManagementRA Capital Management | $23.3M | 5.66% | 0.00% | |
| 5 | Frazier Life Sciences ManagementFrazier Life Sciences | $22.5M | 5.46% | +9.04% | |
| 6 | State StreetState Streetindex-like | $20.3M | 4.93% | +22.04% | |
| 7 | Vestal Point CapitalVestal Point Capital | $20.1M | 4.89% | −3.46% | |
| 8 | Paradigm Biocapital AdvisorsParadigm Biocapital | $19.4M | 4.73% | −32.48% | |
| 9 | Jupiter TopcoJupiter Topco | $18.4M | 4.48% | — | |
| 10 | Orbimed AdvisorsOrbimed | $18.4M | 4.47% | +9.59% | |
| 11 | Citadel AdvisorsCitadel | $18.1M | 4.41% | +1.37% | |
| 12 | Vanguard Capital ManagementVanguardindex-like | $14.6M | 3.54% | +3.95% | |
| 13 | Millennium ManagementMillennium | $13.2M | 3.21% | +75.70% | |
| 14 | Woodline PartnersWoodline Partners | $11.6M | 2.83% | −9.09% | |
| 15 | Balyasny Asset ManagementBalyasny | $11.2M | 2.73% | +51.78% | |
| 16 | Goldman Sachs GroupGoldman Sachs | $10.0M | 2.43% | +10.24% | |
| 17 | 683 Capital Management683 Capital Management | $8.7M | 2.12% | +56.25% | |
| 18 | Geode Capital ManagementGeodeindex-like | $8.1M | 1.98% | +15.47% | |
| 19 | ADAR1 Capital ManagementADAR1 | $7.3M | 1.77% | +6.72% | |
| 20 | venBio Select AdvisorvenBio Select Advisor | $6.9M | 1.69% | −20.58% | |
| 21 | Qube Research & TechnologiesQube Research & Technologies | $6.4M | 1.56% | +195.63% | |
| 22 | Nantahala Capital ManagementNantahala | $6.1M | 1.47% | +8.33% | |
| 23 | Dimensional Fund AdvisorsDimensional | $6.0M | 1.46% | +16.64% | |
| 24 | Spruce Street CapitalSpruce Street Capital | $4.3M | 1.05% | 0.00% | |
| 25 | Blackstone GroupBlackstone | $4.2M | 1.03% | new |
143 managers report $411.1M of Lexeo Therapeutics on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; Suvretta is largest at 7.23%.
Expected move
No implied move.
No implied move.
No implied move.